...readout. The deal gives Gilead Sciences Inc. (NASDAQ:GILD) a chance to gain full ownership of TTX-080...
...Tizona’s conversations with Gilead began as discussions around licensing of TTX-080 and a second asset, TTX-040...
...integrate many companies simultaneously. Gilead’s option for Tizona also gives it the opportunity to obtain TTX-040...

...the potency of tetracycline more than 100-fold compared with the standard assay, whereas the neurotoxin TTX...

...membrane permeability. SiteOne said it is aware of only one other compound targeting site 1 -tetrodotoxin...
...III trials for cancer-related pain. In 2010, a DMC said a Phase III trial of tetrodotoxin...
...believes its synthetic platform could improve the low therapeutic index of natural toxins such as tetrodotoxin...

...on July 9, the last trading day before the original deal was announced. Wex's TTX tetrodotoxin...

...DMC informed the company that the ongoing double-blind, placebo-controlled, Canadian Phase III TEC-006 trial of tetrodotoxin...
...trial until a decision is made. Wex Pharmaceuticals Inc. (TSX:WXI), Vancouver, B.C. Product: Tetrodotoxin ( TTX...

...review the offer. Wex's TTX tetrodotoxin is in Phase III testing to treat cancer-related pain. TTX...

...offering. Shareholders were eligible to purchase one-and-a-half shares for each existing share held. Wex's Tectin tetrodotoxin...

...Shareholders will be eligible to purchase one-and-a-half shares for each existing share held. Wex's Tectin tetrodotoxin...

...In a double-blind, placebo-controlled Phase IIa trial in 14 methadone-maintained subjects, a 4-day pre-treatment with tetrodotoxin...
...was well tolerated but did not alleviate withdrawal symptoms. Subjects received subcutaneous 30 µg twice-daily tetrodotoxin...
...or until it can find a partner. Wex Pharmaceuticals Inc. (TSE:WXI), Vancouver, B.C. Product: Tetrodin tetrodotoxin...

...located in hippocampus Modulator of undisclosed mechanism Age-related memory loss Preclin (w/ Yamanouchi) International Wex Tetrodin...